HT
TXMD icon

HAP Trading’s TherapeuticsMD TXMD Stock Holding History

HAP Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,184
Closed -$3K – 2364
2022
Q1 		$3K Buy
1,184
+400
+51% +$6.29K ﹤0.01% 2037
2021
Q4 		$2K Buy
784
+272
+53% +$8.15K ﹤0.01% 2393
2021
Q3 		$1K Sell
512
-200
-28% -$8.88K ﹤0.01% 2369
2021
Q2 		$2K Buy
+712
New +$43.1K ﹤0.01% 2266
2021
Q1 		– Sell
-1,734
Closed -$8K – 2423
2020
Q4 		$8K Buy
+1,734
New +$118K ﹤0.01% 1963
2019
Q4 		– Sell
-502
Closed -$9K – 1516
2019
Q3 		$9K Buy
+502
New +$70.8K ﹤0.01% 1070
2019
Q1 		– Sell
-1,064
Closed -$9K – 1378
2018
Q4 		$9K Buy
+1,064
New +$260K ﹤0.01% 968

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return